Outcome in patients with basilar artery occlusion treated conventionally

W J Schonewille1, A Algra, J Serena

  • 1University Medical Centre Utrecht, Department of Neurology, HP G 03.228, PO Box 85500, 3508 GA Utrecht, Netherlands. w.j.schonewille@neuro.azu.nl

Insights

Conventional treatment for basilar artery occlusion yields poor outcomes, with 40% mortality and 65% of survivors dependent. This highlights the need for improved treatment strategies for this condition.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Stroke Medicine

Background:

  • Limited data exists on outcomes following conventional treatment for basilar artery occlusion.
  • Existing data primarily comes from small, highly selected patient series undergoing intra-arterial thrombolysis.

Purpose of the Study:

  • To augment the understanding of outcomes associated with conventional treatment for basilar artery occlusion.
  • To provide a larger dataset on the efficacy of non-thrombolytic therapies.

Main Methods:

  • Retrospective analysis of 82 patients with symptomatic basilar artery occlusion across three centers.
  • Conventional therapy included antiplatelets, anticoagulation, or a combination of both.

Main Results:

  • A high case fatality rate of 40% was observed.
  • Among survivors, 65% experienced significant disability (Rankin score 4-5).
  • Younger patients (<60 years) and those with minor strokes had better outcomes (Rankin score 0-3).

Conclusions:

  • Conventional treatment for basilar artery occlusion is linked to poor functional outcomes in nearly 80% of patients.
  • The findings underscore the urgent need to develop more effective therapeutic interventions.
Abstract